Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular SubtypesGottfrid Sjödahl, Fredrik Liedberg, Johan Abrahamsson et al.|European Urology|2021Cited by 182
Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder: Association with tumor stage, lymph node metastases, FDG-PET findings, and survivalJohan Abrahamsson, Sigurður Guðjónsson, Kristina Aaltonen et al.|Urologic Oncology Seminars and Original Investigations|2017Cited by 41
Different responses to neoadjuvant chemotherapy in urothelial carcinoma molecular subtypesGottfrid Sjödahl, Fredrik Liedberg, Johan Abrahamsson et al.|medRxiv|2021Cited by 26
Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer—A Narrative ReviewGottfrid Sjödahl, Fredrik Liedberg, Johan Abrahamsson et al.|Cancers|2022Cited by 25
Complete metabolic response with [ <sup>18</sup> F]fluorodeoxyglucose‐positron emission tomography/computed tomography predicts survival following induction chemotherapy and radical cystectomy in clinically lymph node positive bladder cancerJohan Abrahamsson, Fredrik Liedberg, Petter Kollberg et al.|British Journal of Urology|2021Cited by 19